Premium
Letter: lipid‐lowering effect of tenofovir disoproxil fumarate in chronic hepatitis B—more evidence is needed. Authors’ reply
Author(s) -
Shaheen A. A.,
AlMattooq M.,
Yazdanfar S.,
Burak K. W.,
Swain M. G.,
Congly S. E.,
Borman M. A.,
Lee S. S.,
Myers R. P.,
Coffin C. S.
Publication year - 2017
Publication title -
alimentary pharmacology and therapeutics
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.308
H-Index - 177
eISSN - 1365-2036
pISSN - 0269-2813
DOI - 10.1111/apt.14282
Subject(s) - tenofovir , medicine , chronic hepatitis , virology , hepatitis b , gastroenterology , virus , human immunodeficiency virus (hiv)
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom